Home > Insider Trading > Filing (0001209191-19-030992)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	Surgical & Medical Instruments & Apparatus (3841)	204327508

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1726322	Leigh Vosseller	C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121	Evp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-05-16	10,000	$2.59	12,009	No	4	M	Direct
Common Stock	Disposition	2019-05-16	10,000	$70.45	2,009	No	4	S	Direct
Common Stock	Acquisiton	2019-05-15	1,256	$16.93	3,265	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2019-05-16	10,000	$0.00	10,000	$2.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000			No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	145	Indirect	Leigh A Vosseller Trust

Footnotes

Represents shares of common stock received upon exercise of a stock option award.
The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2019.
The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $70.35 to $70.60. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2018 through May 15, 2019. This transaction is also exempt under Rule 16b-3(c).
The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee.
Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter.
The expiration date for these options is 10 years from the date of grant.